Increased survival of embryonic nigral neurons when grafted to hypothermic rats

No abstract is available for this paper.

• Publication year

  2000

• Venue

  NeuroReport

• Publication date

  2000-06-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00001756-200006050-00014PMID 10852221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease

  2004cited by this paper
• Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches

  2000cited by this paper
• Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery.

  1999cited by this paper
• Caspase inhibition reduces apoptosis and increases survival of nigral transplants

  1999cited by this paper
• Cellular distribution of the NMDA receptor subunit NMDAR1 in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat.

  1999cited by this paper
• Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.

  1999cited by this paper
• Flunarizine improves the survival of grafted dopaminergic neurons.

  1999cited by this paper
• Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons.

  1998cited by this paper
• Mild hypothermia--a revived countermeasure against ischemic neuronal damages.

  1998cited by this paper
• Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

  1998cited by this paper
• Sustained pharmacological inhibition of nitric oxide synthase does not affect the survival of intrastriatal rat fetal mesencephalic transplants.

  1998cited by this paper
• MK‐801 does not enhance dopaminergic cell survival in embryonic nigral grafts

  1998cited by this paper
• Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.

  1998cited by this paper
• Changes in the extracellular levels of glutamate and aspartate during ischemia and hypoglycemia Effects of hypothermia

  1998cited by this paper
• Brain Temperature Alters Hydroxyl Radical Production during Cerebral Ischemia/Reperfusion in Rats

  1996cited by this paper
• The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.

  1996cited by this paper
• Lazaroids improve the survival of grafted rat embryonic dopamine neurons.

  1994cited by this paper
• Hypothermia Prevents the Ischemia‐Induced Translocation and Inhibition of Protein Kinase C in the Rat Striatum

  1991cited by this paper
• Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

  1991cited by this paper
• Temperature modulation of ischemic neuronal death and inhibition of calcium/calmodulin-dependent protein kinase II in gerbils.

  1990cited by this paper
• Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain.

  1989cited by this paper

• Mouse Embryonic Stem Cells Expressing GDNF Show Enhanced Dopaminergic Differentiation and Promote Behavioral Recovery After Grafting in Parkinsonian Rats

  2021cites this paper
• α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox

  2021cites this paper
• Collagen/heparan sulfate porous scaffolds loaded with neural stem cells improve neurological function in a rat model of traumatic brain injury

  2020cites this paper
• Anti-aggregation Effects of Phenolic Compounds on α-synuclein

  2020cites this paper
• Combination of cell transplantation and glial cell line-derived neurotrophic factor-secreting encapsulated cells in Parkinson's disease

  2018cites this paper
• Syddansk Universitet Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson ’ s Disease

  2017cites this paper
• University of Southern Denmark Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson ’ s Disease

  2017cites this paper
• Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson’s Disease

  2017cites this paper
• Nogo-receptor 1 antagonization in combination with neurotrophin-4/5 is not superior to single factor treatment in promoting survival and morphological complexity of cultured dopaminergic neurons.

  2017cites this paper
• Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson’s Disease

  2017cites this paper
• The Oligomer Hypothesis in α-Synucleinopathy

  2017cites this paper
• University of Southern Denmark Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson’s Disease Perez-Bouza,

  2017cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue : a role for protease activation

  2016cites this paper
• Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease

  2016cites this paper
• 3-MA Inhibits Autophagy and Favors Long-Term Integration of Grafted Gad67–GFP GABAergic Precursors in the Developing Neocortex by Preventing Apoptosis

  2014cites this paper
• The many faces of α-synuclein: from structure and toxicity to therapeutic target

  2012cites this paper
• Combination of Temperature-Sensitive Stem Cells and Mild Hypothermia: A New Potential Therapy for Severe Traumatic Brain Injury

  2012cites this paper
• 28 – Human Embryonic Stem Cells, Dopaminergic Neurons, and Pathways for Developing a Parkinson's Disease Therapy

  2007cites this paper
• Transplantation in Parkinson's disease: The future looks bright.

  2006cites this paper
• Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient

  2005cites this paper
• The Effects of Transforming Growth Factor-β2 on Dopaminergic Graft Survival

  2004cites this paper
• A perspective on transplantation therapy and stem cells for Parkinson's disease.

  2004cites this paper
• Article Commentary: A Perspective on Transplantation Therapy and Stem Cells for Parkinson's Disease1

  2004cites this paper
• The effects of transforming growth factor-beta2 on dopaminergic graft survival.

  2004cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation.

  2003cites this paper
• Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP‐1347

  2003cites this paper
• Strategies for the augmentation of grafted dopamine neuron survival.

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue : a role for protease activation

  2003cites this paper
• Effects of Antioxidant Pretreatment on the Survival of Embryonic Dopaminergic Neurons In Vitro and following Grafting in an Animal Model of Parkinson's Disease

  2002cites this paper
• Book Review: Cellular Replacement Therapy for Parkinson’s Disease—Where We Are Today?

  2002cites this paper
• Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.

  2002cites this paper
• Cellular replacement therapy for Parkinson's disease--where we are today?

  2002cites this paper
• The neurobiology of cell transplantation in Parkinson's disease

  2001cites this paper
• P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

  year unknowncites this paper